73
Participants
Start Date
February 1, 2012
Primary Completion Date
June 28, 2012
Study Completion Date
December 20, 2012
Blood collection
Blood collection at Day 0 (all subjects) and at Month 6 (COPD subjects) for the analysis of serology, cell-mediated immune response.
Swab collection
Nasopharyngeal and oropharyngeal swabs collection at Day 0 (All subjects) and at exacerbation visits (COPD subjects).
Sputum collection
Sputum collection at Day 0 and at exacerbation visits (COPD subjects)
GSK Investigational Site, Brussels
GSK Investigational Site, Liège
GSK Investigational Site, Ghent
Lead Sponsor
GlaxoSmithKline
INDUSTRY